WallStreetZenWallStreetZen

NASDAQ: WHWK
Whitehawk Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for WHWK

Based on 2 analysts offering 12 month price targets for Whitehawk Therapeutics Inc

Min Forecast
$7.00+75.44%
Avg Forecast
$7.50+87.97%
Max Forecast
$8.00+100.5%

Should I buy or sell WHWK stock?

Based on 2 analysts offering ratings for Whitehawk Therapeutics Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although WHWK's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates WHWK as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their WHWK stock forecasts and price targets.

WHWK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-16
lockedlocked$00.00+00.00%2025-12-22

1 of 1

Forecast return on equity

Is WHWK forecast to generate an efficient return?

Company
N/A
Industry
62.56%
Market
166.57%

Forecast return on assets

Is WHWK forecast to generate an efficient return on assets?

Company
N/A
Industry
30.53%

WHWK earnings per share forecast

What is WHWK's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$1.43
Avg 2 year Forecast
-$1.30
Avg 3 year Forecast
-$1.03

WHWK revenue forecast

What is WHWK's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$0.0-100%
WHWK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

WHWK revenue growth forecast

How is WHWK forecast to perform vs Biotechnology companies and vs the US market?

Company
-100%
Industry
36.39%
Market
13.61%
WHWK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
WHWK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

WHWK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
WHWK$3.99$7.50+87.97%Strong Buy
HUMA$0.86$5.42+533.57%Strong Buy
UNCY$7.67$27.50+258.54%Strong Buy
CNTN$3.23N/AN/A
ENLV$0.82$20.00+2,350.98%Buy
View Top Biotech Stocks

Whitehawk Therapeutics Stock Forecast FAQ

Is Whitehawk Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: WHWK) stock is to Strong Buy WHWK stock.

Out of 2 analysts, 1 (50%) are recommending WHWK as a Strong Buy, 1 (50%) are recommending WHWK as a Buy, 0 (0%) are recommending WHWK as a Hold, 0 (0%) are recommending WHWK as a Sell, and 0 (0%) are recommending WHWK as a Strong Sell.

If you're new to stock investing, here's how to buy Whitehawk Therapeutics stock.

What is WHWK's earnings growth forecast for 2026-2028?

(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.82%.

Whitehawk Therapeutics's earnings in 2026 is -$20,596,000.On average, 7 Wall Street analysts forecast WHWK's earnings for 2026 to be -$67,396,693, with the lowest WHWK earnings forecast at -$80,942,107, and the highest WHWK earnings forecast at -$57,485,415. On average, 6 Wall Street analysts forecast WHWK's earnings for 2027 to be -$61,138,429, with the lowest WHWK earnings forecast at -$83,254,739, and the highest WHWK earnings forecast at -$40,140,678.

In 2028, WHWK is forecast to generate -$48,621,900 in earnings, with the lowest earnings forecast at -$80,942,107 and the highest earnings forecast at -$19,326,993.

What is WHWK's revenue growth forecast for 2026-2028?

(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual revenue growth rate of -100% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.61%.

Whitehawk Therapeutics's revenue in 2026 is $7,145,000.On average, 7 Wall Street analysts forecast WHWK's revenue for 2026 to be $0, with the lowest WHWK revenue forecast at $0, and the highest WHWK revenue forecast at $0. On average, 6 Wall Street analysts forecast WHWK's revenue for 2027 to be $0, with the lowest WHWK revenue forecast at $0, and the highest WHWK revenue forecast at $0.

In 2028, WHWK is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is WHWK's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: WHWK) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 30.53%.

What is WHWK's Price Target?

According to 2 Wall Street analysts that have issued a 1 year WHWK price target, the average WHWK price target is $7.50, with the highest WHWK stock price forecast at $8.00 and the lowest WHWK stock price forecast at $7.00.

On average, Wall Street analysts predict that Whitehawk Therapeutics's share price could reach $7.50 by Apr 16, 2027. The average Whitehawk Therapeutics stock price prediction forecasts a potential upside of 87.97% from the current WHWK share price of $3.99.

What is WHWK's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: WHWK) Whitehawk Therapeutics's current Earnings Per Share (EPS) is -$0.33. On average, analysts forecast that WHWK's EPS will be -$1.43 for 2026, with the lowest EPS forecast at -$1.72, and the highest EPS forecast at -$1.22. On average, analysts forecast that WHWK's EPS will be -$1.30 for 2027, with the lowest EPS forecast at -$1.76, and the highest EPS forecast at -$0.85. In 2028, WHWK's EPS is forecast to hit -$1.03 (min: -$1.72, max: -$0.41).

What is WHWK's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: WHWK) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.